Recent trends in non-viral vector-mediated gene delivery

Biotechnology Journal

Volumn 4, Issue 11, 2009, Pages 1559-1572

  Pathak, Atul ^a,c   Patnaik, Soma ^a   Gupta, Kailash Chand ^a,b  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^b CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Cationic polymers; Gene delivery; Lipids; Non viral vectors; Transfection

Indexed keywords

BIOLOGICAL BARRIER; BIOPHARMACEUTICALS; CATIONIC POLYMERS; CELLULAR BARRIERS; CELLULAR UPTAKE; CHEMICAL METHOD; CURRENT STATUS; ELECTROPORATION; GENE DELIVERY; INCURABLE DISEASE; LIPOPLEXES; NANOMEDICINES; NONVIRAL; NONVIRAL VECTORS; PHYSICAL METHODS; POLYPLEXES; RECENT TRENDS; SHORT INTERFERING RNA; SUBCELLULAR COMPARTMENTS; TARGET CELLS; TRANSGENE EXPRESSION;

BIOCHIPS; GENE TRANSFER; LIPOSOMES; MEDICAL NANOTECHNOLOGY; NUCLEIC ACIDS; OLIGONUCLEOTIDES; PHOSPHOLIPIDS; RNA; VECTORS;

BIOASSAY;

2,3 BIS(OLEOYL)OXYPROPYLTRIMETHYLAMMONIUMCHLORIDE; ALLYLAMINE; CHITOSAN; CYCLODEXTRIN; DENDRIMER; DEXTRAN; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; DOUBLE STRANDED RNA; LIPOPLEX; LIPOSOME; NAKED DNA; NANOCARRIER; NANOPARTICLE; NUCLEIC ACID; OLIGONUCLEOTIDE; PLASMID DNA; POLYETHYLENEIMINE; POLYLYSINE; POLYMER; RNA INDUCED SILENCING COMPLEX; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

CANCER GENE THERAPY; CLINICAL TRIAL; CYTOTOXICITY; ELECTROPORATION; ENDOCYTOSIS; ENDOSOME; HUMAN; IMMUNE RESPONSE; INTERNALIZATION; LIPOSOMAL GENE DELIVERY SYSTEM; MITOCHONDRION; NANOMEDICINE; NANOTECHNOLOGY; NONVIRAL GENE DELIVERY SYSTEM; NUCLEAR LOCALIZATION SIGNAL; PARTICLE SIZE; PRIORITY JOURNAL; REVIEW;

GENE TRANSFER TECHNIQUES; GENETIC VECTORS; LIPOPEPTIDES; LIPOSOMES; NANOMEDICINE; POLYMERS; RNA, SMALL INTERFERING; VEHICLES;

EID: 73449101112     PISSN: 18606768     EISSN: 18607314     Source Type: Journal    
DOI: 10.1002/biot.200900161     Document Type: Review

References (71)

1. Leonetti, J. P., Mechti, N., Degolos, G., Gagnor, C., Lebleu, B., Intracellular-distribution of microinjected antisense oligonucleotides. Proc. Natl. Acad. Sci. USA 1991, 88, 2702-2706.
2. Srivastava, K. I., Liu, M. A., Gene vaccines. Ann. Intern. Med. 2003, 138, 550-559.
3. Edelstein, M. L., Abedi, M. R., Wixon, J., Gene therapy clinical trials worldwide to 2007, an update. J. Gene Med. 2007, 9, 833-842.
4. Young, L. S., Searle, P. F., Onion, D., Mautner, V., Viral gene therapy strategies: From basic science to clinical applications. J. Pathol. 2006, 208, 299-318.
5. Lonez, C., Vandenbranden, M., Ruysschaert, J. M., Cationic liposomal lipids: From gene carriers to cell signaling. Prog. Lipid Res. 2008, 47, 340-347.
6. Mintzer, M. A., Simanek, E. E., Nonviral vectors for gene delivery. Chem. Rev. 2009, 109, 259-302.
7. Felgner, P. L., Gadek, T. R., Holm, M., Roman, R. et al., Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA 1987, 84, 7413-7417.
8. Gansbacher, B., Report of a second serious adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position of the European Society of Gene Therapy (ESGT). J. Gene Med. 2003, 5, 261-262.
9. Prabha, S., Zhou, W.-Z., Panyam, J., Labhasetwar, V., Size dependency of nanoparticle-mediated gene transfection: Studies with fractionated nanoparticles. Int. J. Pharm. 2002, 244, 105-115.
10. Rejman, J., Oberle, V., Zuhron, I. S., Hoekstra, D., Size dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem. J. 2004, 377, 159-169.
11. Ledley, F. D., Pharmaceutical approach to somatic gene therapy. Pharm. Res. 1996, 13, 1595-1614.
12. Mahato, R. I., Rolland, A., Tomlinson, E., Cationic lipid-based gene delivery systems: Pharmaceutical perspectives. Pharm. Res. 1997, 14, 853-859.
13. Mumper, R. J., Duguid, J. G., Anwer, K., Barron, M. K. et al., Polyvinyl derivatives as novel interactive polymers for controlled gene delivery to muscle. Pharm. Res. 1996, 13, 701-709.
14. Kawabata, K., Takakura, Y., Hashida, M., The fate of plasmid DNA after intravenous injection in mice: Involvement of scavenger receptors in its hepatic uptake. Pharm. Res. 1995, 12, 825-830.
15. Houk, B. E., Hochhaus, G., Hughes, J. A., Kinetic modeling of plasmid DNA degradation in rat plasma. AAPS Pharm. Sci. 1999, 1, E9.
16. Read, M. L., Logan, A., Seymour, L. W., Barriers to gene delivery using synthetic vectors. Adv. Genet. 2005, 53, 19-46.
17. Gupta, B., Levchenko, T. S., Torchilin, V. P., Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides. Adv. Drug Deliv. Rev. 2005, 57, 637-651.
18. Watson, P., Jones, A. T., Stephens, B., Intracellular trafficking pathways and drug delivery: Fluorescence imaging of living and fixed cells. Adv. Drug Deliver. Rev. 2005, 57, 43-61.
19. Hashida, M., Nishikawa, M., Yamashita F., Takakura, Y., Cell-specific delivery of genes with galactosylated carriers. Adv. Drug Deliv. Rev. 2001, 52, 187-196.
20. Caracciolo, G., Caminiti, R., Digman, M. A., Gratton, E., Sanchez, S., Efficient escape from endosomes determines the superior efficiency of multicomponent lipoplexes. J. Phys. Chem. B 2009, 113, 4995-4997.
21. Boussif, O., Lezoualc'h, F., Zanta, M. A., Mergny, M. D. et al., A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine. Proc. Natl. Acad. Sci. USA 1995, 92, 7297-7301.
22. Thomas, M., Klibanov, A. M., Enhancing polyethylenimine's delivery of plasmid DNA into mammalian cells. Proc. Natl. Acad. Sci. USA 2002, 99, 14640-14645.
23. Suh, J., Wirtz, D., Hanes, J., Efficient active transport of gene nanocarriers to the cell nucleus. Proc. Natl. Acad. Sci. USA 2003, 100, 3878-3882.
24. Nguyen, D. N., Green, J. J., Chan, J. M., Langer, R., Anderson, D. G., Polymeric materials for gene delivery and DNA vaccination. Adv. Mater. 2009, 21, 847-867.
25. Schaffer, D. V., Fidelman, N. A., Dan, N., Lauffenburger, D. A., Vector unpacking as a potential barrier for receptor-mediated polyplex gene delivery. Biotechnol. Bioeng. 2000, 67, 598-606.
26. Magin-Lachmann, C., Kotzamanis, G., D'Aiuto, L., Cooke, H., Huxley, C., Wagner, E., In vitro and in vivo delivery of intact BAC DNA-comparison of different methods. J. Gene Med. 2004, 6, 195-209.
27. Andre, F., Mir, L. M., DNA electrotransfer: Its principles and an updated review of its therapeutic applications. Gene Ther. 2004, 11, S33-42.
28. Scherer, F., Anton, M., Schillinger, U., Henke, J. et al., Magnetofection: Enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Ther. 2002, 9, 102-109.
29. Amiji, M. M. (Ed.), Polymeric Gene Delivery: Principles and Applications, CRC Press, Boca Raton 2004.
30. Al-Dosari, M. S., Knapp, J. E., Liu, D., Hydrodynamic delivery. Adv. Genet. 2005, 54, 65-82.
31. Trubetskoy, V. S., Wong, S. C., Subbotin, V., Budker, V. G. et al., Recharging cationic DNA complexes with highly charged polyanions for in vitro and in vivo gene delivery. Gene Ther. 2003, 10, 261-271.
32. Zhang, G., Budker, V., Williams, P., Subbotin, V., Wolff, J. A., Efficient expression of naked DNA delivered intraarterially to limb muscles of nonhuman primates. Hum. Gene Ther. 2001, 12, 427-438.
33. Azzam, T., Domb, A. J., Current developments in gene transfection agents. Curr. Drug Delivery 2004, 1, 165-193.
34. Kulkarni, V. I., Shenoy, V. S., Dodiya, S. S., Rajyaguru, T. H., Murthy, R. R., Role of calcium in gene delivery. Exp. Opin. Drug Deliv. 2006, 3, 235-245.
35. Hoffman, R. M., Margolis, L. B., Bergelson, L. D., Binding and entrapment of high molecular weight DNA by lecithin liposomes. FEBS Lett. 1978, 93, 365-368.
36. Zhang, W., Chen, Z., Song, X., Si, J., Tang, G., Low generation polypropylenimine dendrimer graft beta-cyclodextrin: An efficient vector for gene delivery system. Technol. Cancer Res. Treat. 2008, 7, 103-108.
37. Maitani, Y., Aso, Y., Yamada, A., Yoshioka, S., Effect of sugars on storage stability of lyophilized liposome/DNA complexes with high transfection efficiency. Int. J. Pharm. 2008, 356, 69-75.
38. Godbey, W. T., Wu, K. K., Mikos, A. G., Poly(ethylenimine) and its role in gene delivery. J. Control. Release 1999, 60, 149-160.
39. Sung, S. -J., Min, S. H., Cho, K. Y., Lee, S. et al., Effect of polyethylene glycol on gene delivery of polyethylenimine. Biol. Pharm. Bull. 2003, 26, 492-500.
40. Pun, S. H., Bellocq, N. C., Liu, A., Machemer, T. et al., Cyclodextrin-poly(ethylenimine) polymers for gene delivery. Bioconjug. Chem. 2004, 15, 831-840.
41. Ahn, H. H., Lee, J. H., Kim, K. S., Lee, J. Y. et al., Polyethyleneimine-mediated gene delivery into human adipose derived stem cells. Biomaterials 2008, 29, 2415-2422.
42. Burke, R. S., Pun, S. H., Extracellular barriers to in vitro PEI and PEGylated PEI polyplex-mediated gene delivery to the liver. Bioconjug. Chem. 2008, 19, 693-704.
43. Kim, Y. H., Park, J. H., Lee, M., Kim, Y.-H. et al., Polyethylenimine with acid-labile linkages as a biodegradable gene carrier. J. Control. Release 2005, 103, 209-219.
44. Winblade, N. D., Nikolic, I. D., Hoffman, A. S., Hubbell, J. A., Blocking adhesion to cell and tissue surfaces by the chemisorption of a poly-L-lysine-graft-[poly(ethylene glycol); phenylboronic acid] co-polymer. Biomacromolecules 2000, 1, 523-533.
45. Park, S., Healy, K. E., Nanoparticulate DNA packaging using terpolymers of poly(lysine-g-lactide-b-ethylene glycol). Bioconjug. Chem. 2003, 14, 311-319.
46. Oh, S., Rih, J., Kwon, H., Hwang, D. S. et al., Lactoferrin as a gene delivery vehicle to hepatocytes. Exp. Mol. Med. 1997, 29, 11-16.
47. Yang, C. Q., Wang, J. Y., He, B. M., Liu, J. J., Guo, J. S., Glycopoly-L-lysine is better than liposomal delivery of exogenous genes to rat of liver.World J. Gastroenterol. 2000, 6, 526-531.
48. Takei, Y., Maruyama, A., Ikejima, K., Enomoto, N. et al., Genetic manipulation of sinusoidal endothelial cells. J. Gastroenterol. Hepatol. Suppl. 2007, 1, 68-72.
49. Meyer, M., Zintchenko, A., Ogris, M., Wagner, E., A dimethylmaleic acid-melittin-polylysine conjugate with reduced toxicity, pH-triggered endosomolytic activity and enhanced gene transfer potential. J. Gene Med. 2007, 9, 797-805.
50. Kaneshiro, T. L., Wang, X., Lu, Z. R., Synthesis, characterization, and gene delivery of poly-L-lysine octa(3-aminopropyl) silsesquioxane dendrimers: Nanoglobular drug carriers with precisely defined molecular architectures. Mol. Pharm. 2007, 4, 759-768.
51. Clements, B. A., Incani, V., Kucharski, C., Lavasanifar, A. et al., A comparative evaluation of poly-L-lysine-palmitic acid and Lipofectamine 2000 for plasmid delivery to bone marrow stromal cells. Biomaterials 2007, 28, 4693-4704.
52. Boussif, O., Delair, T., Brua, C., Veron, L. et al., Synthesis of polyallylamine derivative and their use as a gene transfer vectors in vitro. Bioconjug. Chem. 1999, 10, 877-883.
53. Nimesh, S., Kumar, R. Chandra, R., Novel polyallylaminedextran sulfate-DNA nanoplexes: Highly efficient non-viral vector for gene delivery. Int. J. Pharm. 2006, 320, 143-149.
54. Pathak, A., Aggarwal, A., Kurupati, R. K., Patnaik, S. et al., Engineered polyallylamine nanoparticles for efficient in vitro transfection. Pharm. Res. 2007, 24, 1427-1440.
55. Ghosen, B., Kasturi, S. P., Roy, K., Enhancing polysaccharide-mediated delivery of nucleic acids through functionalization with secondary and tertiary amines. Curr.Top. Med. Chem. 2008, 8, 331-340.
56. De la Fuente, M., Seijo, B., Alonso, M. J., Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapy. Invest. Ophthalmol. Vis. Sci. 2008, 49, 2016-2024.
57. Jin, H., Xu, C. X., Kim, H. W., Chung, Y. S. et al., Urocanic acid-modified chitosan-mediated PTEN delivery via aerosol suppressed lung tumorigenesis in K-ras (LA1) mice. Cancer Gene Ther. 2008, 15, 275-283.
58. Hashimoto, M., Morimoto, M., Saimoto, H., Shigemasa, Y., Sato, T., Lactosylated chitosan for DNA delivery into hepatocytes: The effect of lactosylation on the physicochemical properties and intracellular trafficking of pDNA/chitosan complexes. Bioconjug. Chem. 2006, 17, 309-316.
59. Issa, M. M., Köping-Höggård, M., Tømmeraas, K., Vårum, K. M. et al., Targeted gene delivery with trisaccharide-substituted chitosan oligomers in vitro and after lung administration in vivo. J. Control. Release 2006, 115, 103-112.
60. Tomalia, D. A., Baker, H., Dewald, J., Hall, M. et al., A new class of polymers-starburst-dendritic macromolecules. Polym. J. 1985, 17, 117-132.
61. Dung, T. H., Kim, J., Kim, M. S., Kim, J. S., Yoo, H., Preparation and biophysical characterization of pluronic F127-dendrimer conjugate as a delivery agent of antisense oligonucleotides. J. Nanosci. Nanotechnol. 2008, 8, 5326-5330.
62. Fu, H. L., Cheng, S. X., Zhang, X. Z., Zhua, R. X., Dendrimer/DNA complexes encapsulated in a water soluble polymer and supported on fast degrading star poly (DL-lactide) for localized gene delivery. J. Control. Release 2007, 124, 181-188.
63. Schatzlein, A. G., Zinselmeyer, B. H., Elouzi, A., Dufes, C. et al., Preferential gene expression with polypropylenimine dendrimers. J. Control. Release 2005, 101, 247-258.
64. Midoux, P., Pichon, C., Yaouanc, J.-J., Jaffres, P.-A., Chemical vectors for gene delivery: A current review on polymers, peptides and lipids containing histidine or imidazole as nucleic acids carriers. Br. J. Pharmacol. 2009, 157, 166-178.
65. Gao, K., Huang, L., Nonviral methods for siRNA delivery. Mol. Pharm. 2009, 6, 651-658.
66. Moghimi, S. M., Symonds, P., Murray, J. C., Hunter, A. C., et al., A two-stage poly(ethylenimine)-mediated cytotoxicity: Implications for gene transfer/therapy. Mol. Ther. 2005, 11, 990-995.
67. Gao, X., Liu, D., Selective chemical modification on polyethylenimine and its effects on transfection efficiency and cytotoxicity. Mol. Ther. 2005, 11, S427.
68. Stasko, N. A., Johnson, C. B., Schoenfisch, M. H., Johnson, T. A., Holmuhamedov, E. L., Cytotoxicity of polypropylenimine dendrimer conjugates on cultured endothelial cells. Biomacromolecules 2007, 8, 3853-3859.
69. Luten, J., van Nostrum, C. F., De Smedt, S. C., Hennink, W. E., Biodegradable polymers as non-viral carriers for plasmid DNA delivery. J. Control. Release 2008, 126, 97-110.
70. Lin, C., Engbersen, F. J., Effect of chemical functionalities in poly(amidoamine)s for nonviral gene transfection. J. Control. Release 2008, 132, 267-272.
71. Lui, V. W.-Y., Huang, L., Nonviral approaches for cancer gene therapy in: Roland, A., Sullivan, S. M. (Eds.), Pharmaceutical Gene Delivery Systems, Marcel Dekker Press, NY, 2003, pp. 279-320.